Concepedia

Martin F. M. de Rooij

MF

6

Publications

849

Citations

6

H-Index

2011

Active since

Affiliations

University of Amsterdam(Current)

Amsterdam UMC Location University of Amsterdam

The Netherlands Cancer Institute

Pharmacyclics (United States)

Oncode Institute

Martin F. M. de Rooij is an author at University of Amsterdam specializing in cell biology, immunology, and cancer research.

Top concepts

Publications per year

2011–2022

6

Publications

6

The clinically active BTK inhibitor PCI-32765 targets B-cell receptor– and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia

Martin F. M. de Rooij, Annemieke Kuil, Christian R. Geest et al. · Blood · 2012 · 549 citations · Full text

Egress of CD19+CD5+ cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients

Betty Chang, Michelle Francesco, Martin F. M. de Rooij et al. · Blood · 2013 · 204 citations · Full text

N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation

Richard W.J. Groen, Martin F. M. de Rooij, Kinga A. Kocemba‐Pilarczyk et al. · Haematologica · 2011 · 42 citations · Full text

The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

Rachel Thijssen, Johanna ter Burg, Gregor G. W. van Bochove et al. · Leukemia · 2015 · 21 citations

, , +5

Inhibition of casein kinase 2 sensitizes mantle cell lymphoma to venetoclax through MCL-1 downregulation

Yvonne J. Thus, Martin F. M. de Rooij, Nathalie Swier et al. · Haematologica · 2022 · 20 citations · Full text

, , +16

Rows per page

1–5 of 6